Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling von Siebermair, J., Köhler, M.I., Kupusovic, J., Nekolla, S.G., Kessler, L., Ferdinandus, J., Guberina, N., Stuschke, M., Grafe, H., Siveke, J.T., Kochhäuser, S., Fendler, W.P., Totzeck, M., Wakili, R., Umutlu, L., Schlosser, T., Rassaf, T., Rischpler, C.

Volltext

Equivalent tumor detection for early and late FAPI-46 PET acquisition von Ferdinandus, J., Kessler, L., Hirmas, N., Trajkovic-Arsic, M., Hamacher, R., Umutlu, L., Nader, M., Zarrad, F., Weber, M., Fendler, W. P.

Volltext

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial von Cadorna-Carlos, Josefina B, Nolan, Terry, Borja-Tabora, Charissa Fay, Santos, Jaime, Montalban, M. Cecilia, de Looze, Ferdinandus J, Eizenberg, Peter, Hall, Stephen, Dupuy, Martin, Hutagalung, Yanee, Pépin, Stéphanie, Saville, Melanie

Volltext

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD1... von Ferdinandus, J., Müller, H., Damaschin, C., Jacob, A.S., Meissner, J., Krasniqi, F., Mey, U., Schöndube, D., Thiemer, J., Mathas, S., Zijlstra, J., Greil, R., Feuring-Buske, M., Markova, J., Rüffer, J.U., Kobe, C., Eich, H.-T., Baues, C., Fuchs, M., Borchmann, P., Behringer, K.

Volltext

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials von López-Fauqued, Marta, Campora, Laura, Delannois, Frédérique, El Idrissi, Mohamed, Oostvogels, Lidia, De Looze, Ferdinandus J., Diez-Domingo, Javier, Heineman, Thomas C., Lal, Himal, McElhaney, Janet E., McNeil, Shelly A., Yeo, Wilfred, Tavares-Da-Silva, Fernanda, Ahonen, Anitta, Avelino-Silva, Thiago Junquera, Barba-Gomez, Jose Fernando, Berglund, Johan, Cuixart, Carlos Brotons, Caso, Covadonga, Chlibek, Roman, Choi, Won Suk, Cunningham, Anthony L., Desole, Maria Guiseppina, Eizenberg, Peter, Esen, Meral, Espié, Emmanuelle, Gervais, Pierre, Ghesquiere, Wayne, Godeaux, Olivier, Gorfinkel, Iris, Hui, David Shu Cheong, Hwang, Shinn-Jang, Korhonen, Tiina, Kovac, Martina, Ledent, Edouard, Leung, Edward, Levin, Myron J., Perez, Silvia Narejos, Neto, Jose Luiz, Pauksens, Karlis, Poder, Airi, de la Pinta, Maria Luisa Rodriguez, Rombo, Lars, Schwarz, Tino F., Smetana, Jan, Staniscia, Tommaso, Tinoco, Juan Carlos, Toma, Azhar, Vastiau, Ilse, Vesikari, Timo, Volpi, Antonio, Watanabe, Daisuke, Weckx, Lily Yin, Zahaf, Toufik

Volltext

On the intrinsic moisture permeation rate of remote microwave plasma-deposited silicon nitride layers von van Assche, Ferdinandus J.H., Unnikrishnan, Sandeep, Michels, Jasper J., van Mol, Antonius M.B., van de Weijer, Peter, van de Sanden, Mauritius C.M., Creatore, Mariadriana

Volltext

Soluble immune checkpoints HVEM and TIM‐3 are prognostic biomarkers for outcome in classical Hodgkin lymphoma von Ferdinandus, J., Cirillo, M., Bröckelmann, P. J., Tresckow, B., Klapper, W., Engert, A., Borchmann, P., Borchmann, S.

Volltext

Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial von Proietto, Joseph, Malloy, Jaret, Zhuang, Dongliang, Arya, Mark, Cohen, Neale D., de Looze, Ferdinandus J., Gilfillan, Christopher, Griffin, Paul, Hall, Stephen, Nathow, Thomas, Oldfield, Geoffrey S., O’Neal, David N., Roberts, Adam, Stuckey, Bronwyn G. A., Yue, Dennis, Taylor, Kristin, Kim, Dennis

Volltext

CORRELATION BETWEEN PROGRESSION‐FREE AND OVERALL SURVIVAL IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A COMPREHENSIVE ANALYSIS OF INDIVIDUAL PATIENT DATA FROM GHSG TRIALS von Bröckelmann, P. J., Müller, H., Gillessen, S., Jacob, A., Momotow, J., Damaschin, C., Ferdinandus, J., Yang, X., Fuchs, M., Kobe, C., Eich, H., Engert, A., Borchmann, P., Tresckow, B.

Volltext

Impact of PET‐2 guided treatment de‐escalation on time‐to‐recovery from cancer‐related fatigue in advanced stage Hodgkin Lymphoma: results from the GHSG HD18 study von Ferdinandus, J., Müller, H., Damaschin, C., Jacob, A. S., Meissner, J., Krasniqi, F., Mey, U., Schöndube, D., Thiemer, J., Mathas, S., Zijlstra, J. M., Greil, R., Feuring‐Buske, M., Markova, J., Kobe, C., Eich, H. T., Baues, C., Fuchs, M., Behringer, K., Borchmann, P.

Volltext

Toxicities at one year follow‐up in patients with advanced stage classical Hodgkin Lymphoma: results from the randomized phase III HD21 trial by the German Hodgkin Study Group von Ferdinandus, J., Moccia, A. A., Greil, R., Hertzberg, M., Schaub, V., Hüttmann, A., Keil, F., Dierlamm, J., Hänel, M., Novak, U., Meissner, J., Zimmermann, A., Mathas, S., Zijlstra, J. M., Fosså, A., Viardot, A., Hertenstein, B., Martin, S., Giri, P., Kamper, P., Molin, D., Kreissl, S., Fuchs, M., Behringer, K., Schneider, G., Rosenwald, A., Klapper, W., Eich, H. T., Baues, C., Hallek, M., Dietlein, M., Kobe, C., Diehl, V., Engert, A., Borchmann, P.

Volltext

BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL von Borchmann, P., Moccia, A. A., Greil, R., Schneider, G., Hertzberg, M., Schaub, V., Hüttmann, A., Keil, F., Dierlamm, J., Hänel, M., Novak, U., Meissner, J., Zimmermann, A., Mathas, S., Zijlstra, J. M., Fosså, A., Viardot, A., Hertenstein, B., Martin, S., Giri, P., Kamper, P., Molin, D., Kreissl, S., Ferdinandus, J., Fuchs, M., Rosenwald, A., Klapper, W., Eich, H., Baues, C., Hallek, M., Dietlein, M., Kobe, C., Diehl, V., Engert, A.

Volltext

Impact of nurse-mediated management on achieving blood pressure goal levels in primary care: Insights from the Valsartan Intensified Primary carE Reduction of Blood Pressure Study von Carrington, Melinda J, Jennings, Garry L, Harris, Mark, Nelson, Mark, Schlaich, Markus, Stocks, Nigel P, Burrell, Louise M, Amerena, John, de Looze, Ferdinandus J, Swemmer, Carla H, Kurstjens, Nicol P, Stewart, Simon

Volltext

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial von Stewart, Simon, Carrington, Melinda J, Swemmer, Carla H, Anderson, Craig, Kurstjens, Nicol P, Amerena, John, Brown, Alex, Burrell, Louise M, de Looze, Ferdinandus J, Harris, Mark, Hung, Joseph, Krum, Henry, Nelson, Mark, Schlaich, Markus, Stocks, Nigel P, Jennings, Garry L

Volltext

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction o... von Stewart, Simon, Stocks, Nigel P, Burrell, Louise M, de Looze, Ferdinandus J, Esterman, Adrian, Harris, Mark, Hung, Joseph, Swemmer, Carla H, Kurstjens, Nicol P, Jennings, Garry L, Carrington, Melinda J

Volltext

Natural history of Ross River virus‐induced epidemic polyarthritis von Mylonas, Andrea D, Brown, Allison M, Carthew, Tracy L, Purdie, David M, Pandeya, Nirmala, Collins, Louisa G, Suhrbier, Andreas, McGrath, Barry, Reymond, Elizabeth J, Vecchio, Philip C, Gardner, Ian D, Looze, Ferdinandus J

Volltext

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial von Ferdinandus, J., Fendler, W.P., Calais, J., Eiber, M., Flavell, R.R., Mishoe, A., Feng, F.Y., Nguyen, H.G., Reiter, R.E., Rettig, M.B., Gartmann, J., Smith, R., Small, E.J., Slavik, R., Carroll, P.R., Herrmann, K., Czernin, J., Hope, T.A.

Volltext

Das Hodgkin-Lymphom in fortgeschrittenen Stadien von Ferdinandus, J., Oertel, M., Eichenauer, D. A., Meissner, J., Engert, A., Borchmann, P.

Volltext

Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes von Roberts, Michael S., Stokes, Julie A., King, Michelle A., Lynne, Teresa A., Purdie, David M., Glasziou, Paul P., Wilson, D. Andrew J., McCarthy, Sean T., Brooks, Geoffrey E., De Looze, Ferdinandus J., Del Mar, Christopher B.

Volltext

Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy (vol 9, e002262, 2021) von Ferdinandus, J., Metzenmacher, M., Kessler, L.

Volltext